Tdx Glucose
by Abbott Laboratories 510(k)
Active
510(k) K833069
Overview
The Tdx Glucose is a glucose oxidase, glucose device used for the quantitative measurement of glucose in clinical chemistry settings. It functions as a diagnostic tool to assist in the assessment of glucose levels.
This device is manufactured by Abbott Laboratories and is authorized under FDA 510(k) clearance K833069. It is classified as a Class II device under product code CGA.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK833069 | Date7 Nov 1983 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CGA
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1345
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Other devices from Abbott Laboratories
Questions
What is the primary purpose of the Tdx Glucose device?
The Tdx Glucose is a diagnostic tool designed for the quantitative measurement of glucose levels. It is intended for use within clinical chemistry settings to assist healthcare professionals in the assessment of a patient's glucose status.
What is the regulatory classification of this device?
The Tdx Glucose is classified as a Class II medical device under product code CGA. It received FDA 510(k) clearance under the number K833069, confirming it is substantially equivalent to legally marketed predicate devices.
Who is the manufacturer of the Tdx Glucose?
This device is manufactured by Abbott Laboratories, based in Abbott Park, Illinois.